The Green Organic Dutchman Holdings Ltd.’s (“TGOD”) (TSX:TGOD) is pleased to announce it has signed a letter of intent (“LOI”) for a 50/50 joint venture (“JV”) with Queen Genetics/Knud Jepsen A/S (“Knud Jepsen”) based in Hinnerup, Denmark. The JV will initially consist of 200,000 sq. ft. located within Knud Jepsen’s  1.3 million sq. ft. state-of-the-art automated greenhouses in Denmark. The approximately 200,000 square feet of advanced buildings to be dedicated to the JV were designed and engineered by Thomas Larssen of Aurora Larssen Projects Inc. and will provide an opportunity for TGOD to increase its total organic funded capacity by approximately 25,000 kgs. This will provide a consistent supply of high-quality organic cannabis grown in Europe, ready for the local European markets and increases TGOD’s funded capacity to 195,000 kgs.

The JV will focus on the cultivation of premium organic cannabis and primary extraction following TGOD’s organic growing protocols and using Knud Jepsen’s years of advanced R&D directed towards plant genetics and breeding, including many patented discoveries that could be applied towards the cultivation of premium organic medicinal cannabis. TGOD will have the exclusive right to all cannabis-related production at the JV through a guaranteed offtake agreement at a pre-determined value over the production cost to the JV.


Founded in 1939, Knud Jepsen has more than 75 years of experience in all areas of horticulture ranging from genetics and breeding to international partnerships and setting-up global distribution networks. Knud Jepsen is the world’s largest Kalanchoes breeder and producer distributing and selling more than 35 million finished plants in Europe and 90 million cuttings to over 75 countries each year. Over 425 people are employed by Knud Jepsen within their global operations which in addition to Denmark include an 880,000 sq. ft. flower and young plant production facility in Turkey, and a 700,000 sq. ft. facility in Vietnam specializing in producing cuttings belonging to the Queen® Genetic assortment.

A strong focus on R&D has been at the core of Knud Jepsen’s operations since inception with special attention paid to genetic stock development and novel trait identification with a goal to create plants that have consistent regulated heights, are more compact, have stronger cell walls, are more resistant to disease, and have increased secondary metabolite production. In a testament to their award-winning team, each year between 20-30 new novel traits are introduced, and a partnership with The University of Copenhagen has yielded several registered patents related to their team’s advanced research around Natural Transformance.  Environmental sustainability and energy conservation has also been a core principal of Knud Jepsen where the drive to save energy and reduce power costs within their Denmark operations has led to integrated grid planning in an effort to reduce the overall blended rate of energy through the use of a 6MW natural gas co-generation facility, the extraction of solar energy through heat pumps, the integration of waste-based district heating through a direct pipeline from a biomass waste plant for low-cost heating, as well as planning of energy usage and storage based on production planning and the incorporation of weather forecasts into AI-type energy consumption planning.

“Europe, being home to 750 million people, is a key market, and Knud Jepsen has nearly 3 million sq. ft. of horticultural operations, 75 years of operating experience and a significant focus on R&D providing an incredible platform for TGOD to enter the European market,” said Csaba Reider, the Company’s President. “These first two facilities are simply the first step in our business plan to enter Europe at scale. We look forward to completing our final agreement in the coming weeks,” continued Mr. Reider.

”We are very excited about entering the European market as the leader of international organic cultivation,” said Robert Anderson, TGOD’s CEO. “Organic is one of our key differentiators, and when creating a catalog of higher margin products across varying delivery methods, organic inputs make a significant difference in the end product. This JV establishes TGOD’s product across Europe and increases our funded capacity to 195,000 kgs. This represents another significant step forward as we create the largest organic cannabis brand in the world,” Anderson continued.

“We are excited to partner with TGOD, the global leader in organic cannabis, to launch our company’s cannabis division,” stated Frands Jepsen, Knud Jepsen’s CEO. “This is a symbiotic relationship in which TGOD can leverage our global footprint, 450+ employees, and 75+ years’ operating experience and we can leverage TGOD’s organic cannabis brand, cultivation experience, and proven management team to enter the European cannabis market quickly, and at scale.”

Closing of the transaction is subject to customary conditions, including the signing of definitive documents, completion of satisfactory due diligence, and applicable regulatory approvals.

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg of cultivation facilities in Ontario and Quebec and Jamaica.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

CONTACT INFORMATION

Investor Relations
Email: invest@tgod.ca
Phone: 1 (416) 900-7621
www.tgod.ca

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any particular territory and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Source: globenewswire.ca

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less